Scientific expertise
Optum Epidemiology is at the forefront of epidemiologic methodology and practice.
Driven by research objectives, researchers bring scientific rigor and integrity to protocol design, data analytics and research reporting. Such expertise elevates understanding of the safety and efficacy of drugs, devices, biologics and healthcare delivery.
Unparalleled data assets
Our team has deep experience creating evidence from observational data sources. These resources include insurance claims, electronic and paper medical records, patient and provider surveys, and death registries.
With direct access to the data, we have insight into the most appropriate epidemiologic methodologies and interpretation of results.
Our researchers are adept at creating novel linkages that transcend traditional data limitations and enable a broad view of patient care and health.
- Captures medical and pharmacy encounters, linkable to lab results, death registries and socioeconomic data
- Medical record abstraction to confirm diagnoses, drug exposures and other claims information. Used to obtain covariates, and develop and validate algorithms.
- Structured clinical data
- Enhanced by natural language processing (NLP) of free text electronic clinical notes
- Validation of key terms to identify conditions, diagnoses and exposures that are difficult to capture through traditional data source mining
- Patient populations captured within both the claims and EHR data assets
- Additional data sources (for example, patient and provider surveys, registries)
Related healthcare insights
Article
Studying the impact of treatments on pregnancy and infants can help patients, providers and pharmaceutical companies make key decisions.
Article
Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.
E-book
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.